| Literature DB >> 34024768 |
Hossein Hatami1, Hussein Soleimantabar2, Mehrdad Ghasemian3, Negar Delbari4, Shayan Aryannezhad5.
Abstract
BACKGROUND: The rapid increase in the spread of COVID-19 and the numbers of infected patients worldwide has highlighted the need for intensive care unit (ICU) beds and more advanced therapy. This need is more urgent in resource-constrained settings. The present study aimed to identify the predictors of ICU admission among hospitalized COVID-19 patients. STUDYEntities:
Keywords: COVID-19; Critical care; Intensive Care Units; Risk factors; SARS-CoV-2
Mesh:
Year: 2021 PMID: 34024768 PMCID: PMC8957696 DOI: 10.34172/jrhs.2021.44
Source DB: PubMed Journal: J Res Health Sci ISSN: 2228-7795
Demographic and epidemiologic characteristics of hospitalized COVID-19 patients
|
|
|
|
| ||||
|
|
|
|
|
|
|
| |
| Sex | 0.560 | ||||||
| Male | 370 | 55.6 | 295 | 53.9 | 75 | 63.6 | |
| Female | 295 | 44.4 | 252 | 46.1 | 43 | 36.4 | |
| Age (yr) | 0.001 | ||||||
| <40 | 89 | 13.4 | 82 | 15.0 | 7 | 5.9 | |
| 40-60 | 230 | 34.6 | 203 | 37.1 | 27 | 22.9 | |
| 60-80 | 257 | 38.6 | 200 | 36.6 | 57 | 48.3 | |
| ≥80 | 89 | 13.4 | 62 | 11.3 | 27 | 22.9 | |
| Body mass index (kg/m2) | 0.198 | ||||||
| Non-obese (<30) | 236 | 68.0 | 186 | 70.5 | 50 | 78.5 | |
| Obesity (≥30) | 92 | 28.0 | 78 | 29.5 | 14 | 21.5 | |
| Co-morbidities | |||||||
| Diabetes mellitus | 0.116 | ||||||
| No | 481 | 72.5 | 403 | 83.8 | 78 | 66.7 | |
| Yes | 182 | 27.5 | 143 | 26.2 | 39 | 33.3 | |
| Hypertension | 0.001 | ||||||
| No | 440 | 66.5 | 378 | 69.2 | 62 | 53.4 | |
| Yes | 222 | 33.5 | 168 | 30.8 | 54 | 46.6 | |
| Cardiovascular disease | 0.018 | ||||||
| No | 532 | 80.4 | 448 | 82.1 | 84 | 72.4 | |
| Yes | 130 | 19.6 | 98 | 17.9 | 32 | 27.6 | |
| Chronic kidney disease | 0.816 | ||||||
| No | 614 | 92.7 | 507 | 92.9 | 107 | 92.2 | |
| Yes | 48 | 7.3 | 39 | 7.1 | 9 | 7.8 | |
| Chronic obstructive pulmonary disease | 0.259 | ||||||
| No | 649 | 98.0 | 537 | 98.4 | 112 | 96.6 | |
| Yes | 13 | 2.0 | 9 | 1.6 | 4 | 3.4 | |
| Asthma | 0.193 | ||||||
| No | 636 | 96.1 | 527 | 96.5 | 109 | 94.0 | |
| Yes | 26 | 3.9 | 19 | 3.5 | 7 | 6.0 | |
| Malignancy | 0.628 | ||||||
| No | 609 | 92.0 | 501 | 91.8 | 108 | 93.1 | |
| Yes | 53 | 8.0 | 45 | 8.2 | 8 | 6.9 | |
| Immunosuppression | 0.161 | ||||||
| No | 606 | 91.5 | 496 | 90.8 | 110 | 94.8 | |
| Yes | 56 | 8.5 | 50 | 9.2 | 6 | 5.2 | |
| Cerebrovascular accident | 0.029 | ||||||
| No | 632 | 95.3 | 525 | 96.2 | 107 | 91.5 | |
| Yes | 31 | 4.7 | 21 | 3.8 | 10 | 8.5 | |
| Pregnancy | 0.223 | ||||||
| No | 652 | 98.5 | 536 | 98.2 | 116 | 100.0 | |
| Yes | 10 | 1.5 | 10 | 1.8 | 0 | 0.0 | |
| Numbers of co-morbidities | 0.001 | ||||||
| 0 | 222 | 33.4 | 201 | 36.7 | 21 | 17.8 | |
| 1 | 184 | 27.7 | 143 | 26.1 | 41 | 34.7 | |
| 2 | 150 | 22.6 | 119 | 21.8 | 31 | 26.3 | |
| ≥3 | 109 | 16.4 | 84 | 15.4 | 25 | 21.2 | |
Clinical characteristics of hospitalized COVID-19 patients
|
|
|
|
|
| |||
|
|
|
|
|
|
| ||
|
| |||||||
| Cough | 0.236 | ||||||
| No | 248 | 37.4 | 199 | 36.4 | 49 | 19.8 | |
| Yes | 415 | 62.6 | 348 | 63.6 | 67 | 57.8 | |
| Fever | 0.391 | ||||||
| No | 292 | 44.1 | 245 | 44.9 | 47 | 40.5 | |
| Yes | 370 | 55.9 | 301 | 55.1 | 69 | 59.5 | |
| Dyspnea | 0.001 | ||||||
| No | 315 | 47.4 | 277 | 50.6 | 38 | 32.5 | |
| Yes | 349 | 52.6 | 270 | 49.4 | 79 | 67.5 | |
| Myalgia | 0.012 | ||||||
| No | 376 | 56.7 | 298 | 54.5 | 78 | 67.2 | |
| Yes | 287 | 43.3 | 249 | 45.5 | 38 | 32.8 | |
| Fatigue | 0.137 | ||||||
| No | 423 | 63.8 | 342 | 80.9 | 81 | 69.8 | |
| Yes | 240 | 36.2 | 205 | 37.5 | 35 | 30.2 | |
| Chest pain | 0.727 | ||||||
| No | 547 | 82.5 | 450 | 82.3 | 97 | 83.6 | |
| Yes | 116 | 17.5 | 97 | 17.7 | 19 | 16.4 | |
| Sweating | 0.239 | ||||||
| No | 607 | 91.6 | 504 | 92.1 | 103 | 88.8 | |
| Yes | 56 | 8.4 | 43 | 7.9 | 13 | 11.2 | |
| Anorexia | 0.698 | ||||||
| No | 511 | 77.1 | 420 | 76.8 | 91 | 78.4 | |
| Yes | 152 | 22.9 | 127 | 23.2 | 25 | 21.6 | |
| Headache | 0.517 | ||||||
| No | 601 | 90.6 | 494 | 90.3 | 107 | 92.2 | |
| Yes | 62 | 9.4 | 53 | 9.7 | 9 | 7.8 | |
| Sore throat | 1.000 | ||||||
| No | 653 | 98.5 | 538 | 98.4 | 115 | 99.1 | |
| Yes | 10 | 1.5 | 9 | 1.6 | 1 | 0.9 | |
| Diarrhea | 0.391 | ||||||
| No | 623 | 94.0 | 512 | 93.6 | 11 | 95.7 | |
| Yes | 40 | 6.0 | 35 | 6.4 | 5 | 4.3 | |
| Nausea/Vomiting | 0.355 | ||||||
| No | 540 | 81.4 | 442 | 80.8 | 98 | 84.5 | |
| Yes | 123 | 18.6 | 105 | 19.2 | 18 | 15.5 | |
| Abdominal pain | 0.392 | ||||||
| No | 610 | 92.0 | 501 | 91.6 | 109 | 94.0 | |
| Yes | 53 | 8.0 | 46 | 8.4 | 7 | 6.0 | |
| Dizziness | 0.336 | ||||||
| No | 634 | 95.6 | 525 | 96.0 | 109 | 94.0 | |
| Yes | 29 | 4.4 | 22 | 4.0 | 7 | 6.0 | |
| Convulsion | 0.001 | ||||||
| No | 653 | 98.5 | 544 | 99.5 | 109 | 94.0 | |
| Yes | 10 | 1.5 | 3 | 0.5 | 7 | 6.0 | |
| Loss of consciousness | 0.001 | ||||||
| No | 615 | 92.6 | 522 | 95.4 | 93 | 79.5 | |
| Yes | 49 | 7.4 | 25 | 4.6 | 24 | 20.5 | |
| Others | 0.187 | ||||||
| No | 584 | 88.1 | 486 | 88.8 | 98 | 84.5 | |
| Yes | 79 | 11.9 | 61 | 11.2 | 18 | 15.5 | |
|
| |||||||
| Tachycardia | 0.001 | ||||||
| No | 544 | 84.5 | 458 | 86.7 | 86 | 74.1 | |
| Yes | 100 | 15.5 | 70 | 13.3 | 30 | 25.9 | |
| Tachypnea | 0.001 | ||||||
| No | 455 | 79.3 | 386 | 82.3 | 69 | 65.7 | |
| Yes | 119 | 20.7 | 83 | 17.7 | 36 | 34.4 | |
| Temperature (≥38.5) | 0.807 | ||||||
| No | 527 | 83.0 | 434 | 82.8 | 93 | 83.8 | |
| Yes | 108 | 17.0 | 90 | 17.2 | 18 | 16.2 | |
| O2 saturation (Spo2) | 0.001 | ||||||
| ≥95 | 147 | 24.8 | 134 | 27.8 | 13 | 11.7 | |
| 90-94 | 246 | 41.5 | 219 | 45.4 | 27 | 24.3 | |
| <90 | 200 | 33.7 | 129 | 26.8 | 71 | 64.0 | |
Baseline laboratory values of hospitalized COVID-19 patients
|
|
|
|
|
| |||
|
|
|
|
|
|
| ||
| Leukocytes (×109/L) | 0.001 | ||||||
| >11.20 | 105 | 16.3 | 71 | 13.4 | 34 | 29.1 | |
| 4.20-11.20 | 454 | 70.4 | 384 | 72.7 | 70 | 59.8 | |
| <4.20 | 86 | 13.3 | 73 | 13.8 | 13 | 11.1 | |
| Neutrophil count (×109/L) | 0.001 | ||||||
| >7.70 | 134 | 20.9 | 96 | 18.3 | 38 | 32.5 | |
| 1.5-7.7 | 495 | 77.4 | 418 | 80.0 | 77 | 65.8 | |
| <1.50 | 11 | 1.7 | 9 | 1.7 | 2 | 1.7 | |
| Lymphocyte count (×109/L) | 0.001 | ||||||
| >4.00 | 10 | 1.6 | 8 | 1.5 | 2 | 1.7 | |
| 1.00-4.00 | 404 | 63.9 | 350 | 67.8 | 54 | 47.0 | |
| <1.00 | 221 | 34.5 | 161 | 30.7 | 60 | 51.3 | |
| Platelets (×109/L) | 0.253 | ||||||
| >450.0 | 176 | 27.3 | 137 | 25.9 | 39 | 33.3 | |
| 150.0-450.0 | 454 | 70.4 | 379 | 71.8 | 75 | 64.1 | |
| <150.0 | 15 | 2.3 | 12 | 2.3 | 3 | 2.6 | |
| Hemoglobin (g/dL) | 0.475 | ||||||
| ≥12 | 437 | 67.8 | 361 | 68.4 | 76 | 65.0 | |
| <12 | 208 | 32.2 | 167 | 31.6 | 41 | 35.0 | |
| CRP (mg/L) | 0.268 | ||||||
| >10 | 511 | 85.0 | 412 | 84.3 | 99 | 88.4 | |
| ≤10 | 90 | 15.0 | 77 | 15.7 | 13 | 11.6 | |
| ESR (mm/h) | 0.975 | ||||||
| >20 | 330 | 80.1 | 253 | 80.1 | 77 | 80.2 | |
| ≤20 | 82 | 19.9 | 63 | 19.9 | 19 | 19.8 | |
| INR | 0.027 | ||||||
| >1.26 | 82 | 20.1 | 54 | 17.6 | 28 | 27.7 | |
| ≤1.26 | 326 | 79.9 | 253 | 82.4 | 73 | 72.3 | |
| Prothrombin time (s) | 0.032 | ||||||
| >13.6 | 87 | 21.4 | 58 | 18.9 | 29 | 29.0 | |
| ≤13.6 | 320 | 78.6 | 249 | 81.1 | 71 | 71.1 | |
| Partial thrombin time (s) | 0.596 | ||||||
| >40 | 20 | 5.0 | 14 | 4.6 | 6 | 5.9 | |
| ≤40 | 384 | 95.5 | 289 | 95.4 | 05 | 94.1 | |
| PH | 0.001 | ||||||
| >7.41 | 328 | 53.9 | 269 | 54.7 | 59 | 50.4 | |
| 7.31-7.41 | 242 | 29.7 | 202 | 33.2 | 40 | 34.1 | |
| <7.31 | 39 | 6.4 | 21 | 4.3 | 18 | 15.5 | |
| PCO2 (mmHg) | 0.633 | ||||||
| >52.0 | 76 | 12.5 | 60 | 12.2 | 16 | 13.7 | |
| 40.0-52.0 | 326 | 53.5 | 268 | 54.5 | 58 | 49.6 | |
| <40.0 | 207 | 34.0 | 164 | 33.3 | 43 | 36.8 | |
| HCO3 (mEq/L) | 0.254 | ||||||
| >27.00 | 306 | 50.2 | 251 | 51.0 | 55 | 47.0 | |
| 22.0-27.0 | 231 | 37.9 | 188 | 38.2 | 43 | 36.8 | |
| <22.00 | 72 | 11.8 | 53 | 10.8 | 19 | 16.2 | |
| Urea (mg/dl) | 0.001 | ||||||
| >45.0 | 202 | 31.7 | 149 | 28.7 | 53 | 45.3 | |
| ≤45.0 | 435 | 68.3 | 371 | 85.3 | 64 | 54.7 | |
| Serum creatinine (mg/dl) | 0.001 | ||||||
| >1.5 | 128 | 20.1 | 92 | 17.7 | 36 | 31.0 | |
| ≤1.5 | 509 | 79.9 | 429 | 82.3 | 80 | 69.0 | |
| Serum sodium (mmol/L) | 0.001 | ||||||
| >146.00 | 5 | 0.8 | 1 | 0.2 | 4 | 3.4 | |
| 133.0-146.0 | 528 | 86.0 | 438 | 72.8 | 90 | 77.6 | |
| <133.00 | 81 | 13.2 | 59 | 11.8 | 22 | 19.0 | |
| Serum potassium (mmol/L) | 0.482 | ||||||
| >5.00 | 49 | 8.0 | 38 | 7.6 | 11 | 9.5 | |
| 3.80-5.00 | 446 | 72.8 | 359 | 72.2 | 87 | 75.0 | |
| <3.80 | 118 | 19.2 | 100 | 20.1 | 18 | 15.5 | |
| CPK (IU/L) | 0.001 | ||||||
| >195.0 | 173 | 32.1 | 124 | 28.4 | 49 | 48.0 | |
| ≤195.0 | 366 | 67.9 | 313 | 71.6 | 53 | 52.0 | |
| AST (U/L) | 0.001 | ||||||
| >40.0 | 137 | 36.6 | 92 | 31.6 | 45 | 54.2 | |
| ≤40.0 | 238 | 63.4 | 200 | 68.4 | 38 | 45.8 | |
| ALT (U/L) | 0.050 | ||||||
| >50.0 | 60 | 16.1 | 41 | 14.1 | 19 | 23.2 | |
| ≤50.0 | 312 | 83.9 | 249 | 85.9 | 63 | 76.8 | |
| LDH (U/L) | 0.031 | ||||||
| >460.0 | 168 | 66.7 | 119 | 63.0 | 49 | 77.8 | |
| ≤460.0 | 84 | 33.3 | 70 | 37.0 | 12 | 22.2 | |
Radiologic findings of hospitalized COVID-19 patients
|
|
|
|
|
| |||
|
|
|
|
|
|
| ||
| Normal CT finding | 0.013 | ||||||
| No | 456 | 95.0 | 366 | 93.8 | 90 | 100.0 | |
| Yes | 24 | 5.0 | 24 | 6.2 | 0 | 0.0 | |
| Ground glass opacification (GGO) | 0.702 | ||||||
| No | 94 | 19.7 | 75 | 19.3 | 19 | 21.1 | |
| Yes | 384 | 80.3 | 313 | 80.7 | 71 | 78.9 | |
| Consolidation | 0.001 | ||||||
| No | 392 | 81.8 | 330 | 84.4 | 62 | 68.9 | |
| Yes | 87 | 18.2 | 59 | 15.2 | 28 | 31.1 | |
| Nodules | 0.800 | ||||||
| No | 452 | 94.6 | 366 | 94.3 | 86 | 95.6 | |
| Yes | 26 | 5.4 | 22 | 5.7 | 4 | 4.4 | |
| Bilateral lesion distribution | 0.179 | ||||||
| No | 75 | 15.8 | 65 | 16.8 | 10 | 11.1 | |
| Yes | 401 | 84.2 | 321 | 83.2 | 80 | 88.9 | |
| Peripheral lesion distribution | 0.965 | ||||||
| No | 122 | 25.7 | 99 | 25.8 | 23 | 25.6 | |
| Yes | 352 | 74.3 | 285 | 74.2 | 67 | 74.4 | |
| Multifocal lesion distribution | 0.740 | ||||||
| No | 130 | 27.5 | 104 | 27.2 | 26 | 28.9 | |
| Yes | 343 | 72.5 | 279 | 72.8 | 64 | 71.1 | |
| Pleural effusion | <0.001 | ||||||
| No | 418 | 87.4 | 354 | 91.2 | 64 | 71.1 | |
| Yes | 60 | 12.6 | 34 | 8.8 | 26 | 28.9 | |
| Pericardial effusion | 0.238 | ||||||
| No | 473 | 99.0 | 385 | 99.2 | 88 | 97.8 | |
| Yes | 5 | 1.0 | 3 | 0.8 | 2 | 2.2 | |
| Cardiomegaly | 0.001 | ||||||
| No | 413 | 86.4 | 345 | 88.9 | 68 | 75.6 | |
| Yes | 65 | 13.6 | 43 | 11.1 | 22 | 24.4 | |
| Lymphadenopathy | 0.839 | ||||||
| No | 425 | 89.3 | 345 | 89.1 | 80 | 89.9 | |
| Yes | 51 | 10.7 | 42 | 10.9 | 9 | 10.1 | |
| Aortocoronary calcification | 0.018 | ||||||
| No | 369 | 77.7 | 308 | 79.8 | 61 | 68.2 | |
| Yes | 106 | 22.3 | 78 | 20.2 | 28 | 31.8 | |
| Tree in bud | 1.000 | ||||||
| No | 461 | 96.6 | 374 | 96.6 | 87 | 96.7 | |
| Yes | 16 | 3.4 | 13 | 3.4 | 3 | 3.3 | |
| Crazy paving | 0.002 | ||||||
| No | 467 | 98.1 | 384 | 99.2 | 83 | 93.3 | |
| Yes | 9 | 1.9 | 3 | 0.8 | 6 | 6.7 | |
| GGO + Consolidation | 0.077 | ||||||
| No | 430 | 89.6 | 355 | 90.8 | 75 | 84.4 | |
| Yes | 50 | 10.4 | 36 | 9.2 | 14 | 15.6 | |
| GGO + Pleural effusion | 0.001 | ||||||
| No | 435 | 91.0 | 363 | 93.8 | 72 | 78.9 | |
| Yes | 43 | 9.0 | 24 | 6.2 | 19 | 21.1 | |
| Consolidation + Pleural effusion | 0.001 | ||||||
| No | 456 | 95.0 | 381 | 96.7 | 75 | 87.8 | |
| Yes | 24 | 5.0 | 13 | 3.3 | 11 | 12.2 | |
| Bilateral GGO | 0.946 | ||||||
| No | 116 | 24.2 | 94 | 24.1 | 22 | 24.4 | |
| Yes | 364 | 75.8 | 296 | 75.9 | 68 | 75.6 | |
| Bilateral Consolidation | 0.005 | ||||||
| No | 408 | 85.0 | 341 | 87.2 | 67 | 75.4 | |
| Yes | 72 | 15.0 | 50 | 12.8 | 22 | 24.6 | |
| Bilateral Nodules | 0.748 | ||||||
| No | 469 | 96.9 | 381 | 96.7 | 88 | 97.8 | |
| Yes | 15 | 3.1 | 13 | 3.3 | 2 | 2.2 | |
Figure 1